Beiersdorf has announced a significant expansion of its corporate venture capital activities, committing $114 million to its second-generation Skin Care Innovation Fund. This new fund doubles the volume of its predecessor launched in 2020, reinforcing the company's strategic ambition to lead the future of the skin care industry. The initiative aims to accelerate growth by investing in pioneering science-based innovations.
Strategic Investment in Future-Forward Fields
The Skin Care Innovation Fund will concentrate on global investments in companies operating at the intersection of skin care and key technological fields. These core areas include life sciences, biotechnology, sustainability, AI-enabled technologies, and digital health solutions. The fund targets startups from early to growth stages, with initial investments typically ranging from $574.000 to $5.7 million.
Dr. Gitta Neufang, Chief Research & Development Officer at Beiersdorf, highlighted the importance of combining internal expertise with external innovation. She stated that the fund connects scientific advances from startups with Beiersdorf’s extensive R&D capabilities. This synergy is crucial for translating cutting-edge scientific progress into effective and accessible skin care solutions for consumers around the world.
More Than Capital: A Partnership for Growth
Ascan Voswinckel, Head of Beiersdorf Venture Capital, emphasized that the fund offers more than just financial backing. He explained that pioneering ideas require both capital and the right partners to flourish and achieve scale. Startups gain access to Beiersdorf’s leading research expertise and global brand platforms, creating a mutually beneficial relationship that fosters sustainable value.
This partnership model is designed to capitalize on the considerable innovation momentum in key sectors. The fund is actively seeking attractive investment opportunities in emerging areas such as longevity science and AI-driven active ingredient discovery. By providing comprehensive support, Beiersdorf aims to help its portfolio companies navigate the path from concept to commercial success more effectively.
Building on a Successful Venture Model
Since its inception in 2020, Beiersdorf Venture Capital has cultivated a strong portfolio of more than 15 leading companies. These investments span the fund's core focus areas of life science, sustainability, and digital health. Several of these portfolio companies have already achieved significant milestones, delivering both technological collaborations and substantial financial value creation.
A prime example of this success is S-Biomedic, a Belgian leader in skin microbiome science. Following an initial venture capital investment and a multi-year strategic partnership, the company was fully acquired by Beiersdorf. Its technology is now a fundamental part of Beiersdorf's global innovation pipeline, showcasing a complete and successful investment lifecycle.
Advancing Science and Sustainability
The fund is also making significant inroads in the field of longevity science, backing innovative startups like Vincere Biosciences and Turbine. Vincere Biosciences specializes in mitophagy research, while Turbine is a frontrunner in AI-based cell simulation. These collaborations allow Beiersdorf to explore scientifically validated approaches to understanding and addressing the mechanisms of skin aging.
In line with its corporate sustainability goals, Beiersdorf has also invested in companies like DePoly and Melt&Marble. DePoly is developing advanced PET recycling technology, while Melt&Marble focuses on precision fermented lipids. These investments are integral to Beiersdorf's efforts to reduce emissions and support the development of more sustainable solutions across its value chain.
With the launch of its new $114 million Skin Care Innovation Fund, Beiersdorf is significantly deepening its engagement with the global innovation ecosystem. This long-term commitment strengthens the company's ability to translate frontier science into scalable, next-generation skin care solutions. The initiative solidifies Beiersdorf's strategic ambition to become the undisputed authority in skin care through pioneering research and collaboration.